Regis Resources (ASX: RRL) drops Vault Minerals bid, letting Genesis Minerals’s A$5.6bn offer proceed
Read More Pharma Industry News Gilead’s EVOKE-02 study of Trodelvy, KEYTRUDA combo shows promise in NSCLC Gilead Sciences, Inc. announced early data showcasing promising clinical activity of Trodelvy in combination with Merck’s KEYTRUDA for… byPallavi MadhirajuSeptember 10, 2023